Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Hyperinsulinemia in NAFLD: Dexamethasone-Pancreatic Clamp Pilot & Feasibility Study

NCT06126354 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT06126354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06126354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Hyperinsulinemia in NAFLD: Dexamethasone-Pancreatic Clamp Pilot & Feasibility Study
Lead sponsor
Columbia University
Phase
Phase 1
Overall status
Withdrawn
Start date
July 1, 2024
Completion date
March 31, 2026
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, non-alcoholic fatty liver disease, overweight and obesity, prediabetic state